Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v27-EN Version v17-EN
Language English English
Date Updated 2020-01-07 2019-06-27
Drug Identification Number 02018144 02018144
Brand name CYCLOMEN CYCLOMEN
Common or Proper name Cyclomen 50mg Cyclomen 50mg
Company Name SANOFI-AVENTIS CANADA INC SANOFI-AVENTIS CANADA INC
Ingredients DANAZOL DANAZOL
Strength(s) 50MG 50MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 100 100
ATC code G03XA G03XA
ATC description OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2018-09-28 2018-09-28
Actual start date
Estimated end date 2020-01-31 2019-12-02
Actual end date 2020-01-06
Shortage status Resolved Actual shortage
Company comments Delay in manufacturing. Delay in manufacturing. Update June 25, 2019: A small quantity of Cyclomen 100 mg (DIN 02018152) has been secured and is now released; allocation of that stock will be made for pending POs based on ordering history. Overall Cyclomen 50 mg, 100 mg and 200 mg drug shortage is unfortunately still on-going.
Health Canada comments